Don’t let winter ailments slow you down. Discover how understanding your symptoms can lead to powerful relief while embracing ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

While respiratory syncytial virus (RSV) typically causes mild symptoms in adults, the virus can be life-threatening for infants. The seasonal virus is the most common cause of lower respiratory tract ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.

A prominent paediatrician on Sunday urged people to take more precautions against a common virus known as RSV, saying cases ...

Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.

Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season.

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9.

ATLANTA -- U.S. Health Secretary Robert F. Kennedy's new vaccine advisory committee returned to work Thursday, and the panel may vote on proposals about fall flu vaccines and a preservative in some ...

A new study shows that a vaccine against respiratory syncytial virus is associated with a 29% reduction in dementia risk in ...